Losmapimod Protected Epileptic Rats From Hippocampal Neuron Damage Through Inhibition of the MAPK Pathway
Objective: This research aimed to validate the therapeutic effect of losmapimod and explore the underlying mechanism in its treatment of epilepsy.Methods: A rat model of epilepsy was constructed with an injection of pilocarpine. Microarray analysis was performed to screen aberrantly expressed mRNAs...
Main Authors: | Min Li, Lexiang Cui, Xuemin Feng, Chao Wang, Yinmeng Zhang, Lijie Wang, Ying Ding, Teng Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00625/full |
Similar Items
-
Losmapimod Overcomes Gefitinib Resistance in Non-small Cell Lung Cancer by Preventing Tetraploidization
by: Yiu To Yeung, et al.
Published: (2018-02-01) -
Losmapimod: A Novel Clinical Drug to Overcome Gefitinib-Resistance
by: Yukio Nishimura
Published: (2018-02-01) -
Hippocampal Sclerosis in Pilocarpine Epilepsy: Survival of Peptide-Containing Neurons and Learning and Memory Disturbances in the Adult NMRI Strain Mouse
by: Adrienne Mátyás, et al.
Published: (2021-12-01) -
Increased expression of galanin and its receptors in the dorsal hippocampus during epileptogenesis in a rat model of pilocarpine-induced temporal lobe epilepsy
by: Jing Sun, et al.
Published: (2023-11-01) -
Evaluation of losmapimod in patients with chronic obstructive pulmonary disease (COPD) with systemic inflammation stratified using fibrinogen (‘EVOLUTION’): Rationale and protocol
by: M. Fisk, et al.
Published: (2013-11-01)